Tenofovir disoproxil fumarate has a substantial efficacy against multidrug-resistant strains of hepatitis B virus.

Date
2015
Author
Besisik, Fatih
Karaca, Cetin
Badur, Selim
Akyuz, Filiz
Gulluoglu, Mine
Baran, Bulent
Ormeci, Asli Cifcibasi
Evirgen, Sami
Demir, Kadir
Onel, Derya
Kaymakoglu, Sabahattin
Soyer, Ozlem Mutluay
Gokturk, Suut
Metadata
Show full item record
Abstract
Background & AimsTo evaluate the efficacy of tenofovir in chronic hepatitis B (CHB) patients with adefovir resistance (ADF-R) and suboptimal response to adefovir (ADF-S).
URI
http://hdl.handle.net/20.500.12627/165620
https://doi.org/10.1111/liv.12831
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84942365924&origin=inward
Collections